ProstaLund AB engages in the development and marketing of medical technology within urology. It provides products and treatment for Benign Prostatic Hyperplasia (BPH). The firm offers CoreTherm, which is a thermotherapy treatment method for BPH. The company was founded by Magnus Bolmsjö in 1991 and is headquartered in Lund, Sweden.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company